Abstract
C-reactive protein (CRP) has gained significant traction in the medical world due to the discovery of its role in identifying and categorizing cancer. Researchers have worked with CRP in reference to detecting cardiovascular disease and inflammatory infections in the past, and this expansion into cancer has shown that CRPs often play a significant role in the risk, prognosis, and diagnosis of cancer. Single nucleotide polymorphisms (SNPs) in these CRPs have also been seen to have an active role in tumorogenesis and studying certain SNPs has shown increased or decreased risk for certain types of cancer. This chapter includes different SNPs of CRPs and their relationship to diseases ranging from coronary heart disease to breast cancer. While the data for certain SNPs from different experiments can conflict to whether or not it increases the risk of tumorigenesis, it also has shown consistent results for other cases. This method of analysis helps us build a foundation for a novel type of cancer diagnosis, one that can even predict the chance of certain diseases in an individual long before the symptoms may start to manifest.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
Abbreviations
- AD:
-
Alzheimer’s disease
- AMRD:
-
Age-related macular degeneration
- APP:
-
Acute phase protein
- C/EBP:
-
CCAAT-enhancer-binding protein
- CRP:
-
C-reactive protein
- CVD:
-
Cardiovascular disease
- hs-CRP:
-
High-sensitivity CRP
- IL:
-
Interleukin
- LDL:
-
Low-density lipoprotein
- mCRP:
-
Monomeric C-reactive
- NF-kB :
-
Nuclear factor kappa
- NO:
-
Nitric oxide
- pCRP:
-
Pentametric isoform
- PD:
-
Parkinson’s disease
- PRR:
-
Pattern recognition receptor
- S. pneumoniae :
-
Streptococcus pneumoniae
- SAP:
-
Serum amyloid P-competent
- SLE :
-
Systemic lupus erythematosus
- SNP:
-
Single nucleotide polymorphism
- STAT3 :
-
Signal transducer and activator of transcription 3
- T2D:
-
Type 2 diabetes
- TNF:
References
Agrawal A, Cha-Molstad H, Samols D, Kushner I (2003) Overexpressed nuclear factor-kappaB can participate in endogenous C-reactive protein induction, and enhances the effects of C/EBPbeta and signal transducer and activator of transcription-3. Immunology 108(4):539–547
Allin KH, Nordestgaard BG (2011) Elevated C-reactive protein in the diagnosis, prognosis, and cause of cancer. Crit Rev Clin Lab Sci 48(4):155–170
Ancelin ML, Farré A, Carrière I, Ritchie K, Chaudieu I, Ryan J (2015) C-reactive protein gene variants: independent association with late-life depression and circulating protein levels. Transl Psychiatry 5(1):e499. https://doi.org/10.1038/tp.2014.145
Ansar W, Ghosh S (2013) C-reactive protein and the biology of disease. Immunol Res 56(1):131–142. (Review)
Ansar W, Ghosh S (2016) Biology of C reactive protein in health and disease. Springer
Ansar W, Mukhopadhyay S, Habib SKH, Basu S, Saha B, Sen AK, Mandal CN, Mandal C (2009) Disease-associated glycosylated molecular variants of human C-reactive protein activate complement-mediated hemolysis of erythrocytes in tuberculosis and Indian visceral leishmaniasis. Glycoconj J 26:1151
Balaji S, Asegaonkar SB, Asegaonkar BN, Takalkar UV, Suresh Advani S, Thorat AP (2015) C-reactive protein and breast cancer: new insights from old molecule. Int J Breast Cancer:145647. 6 pages. https://doi.org/10.1155/2015/145647
Black S, Kushner I, Samols D (2004a) C-reactive protein. J Biol Chem 279:48487–48490
Black S, Kushner I, Samols D (2004b) C-reactive protein J. Biol Chem 279:48487
Boncler M, Wu Y, Watala C (2019) The Multiple faces of C-reactive protein—physiological and pathophysiological implications in cardiovascular disease. Molecules 24(11):2062
Buie JJ, Renaud LL, Muise-Helmericks R, Oates JC (2017) IFN-α Negatively regulates the expression of endothelial nitric oxide synthase and nitric oxide production: implications for systemic lupus erythematosus. J Immunol 199(6):1979–1988
Burley SK, Berman HM et al (2019) RCSB Protein Data Bank: biological macromolecular structures enabling research and education in fundamental biology, biomedicine, biotechnology and energy. Nucleic Acids Res 47:D464–D474
Cha-Molstad H, Young DP, Kushner I, Samols D (2007) The interaction of C-Rel with C/EBPbeta enhances C/EBPbeta binding to the C-reactive protein gene promoter. Mol Immunol 44(11):2933–2942
Chen RW, Zhou Y, Yuan YJ, Zhang Q, He SS, Chen Y, Ren YF (2019) Effect of CRP and kinetics of CRP in prognosis of nasopharyngeal carcinoma. Front Oncol 9:89. https://www.frontiersin.org/articles/10.3389/fonc.2019.00089/full
Cipriani V, Hogg RE, Sofat R, Moore AT, Webster AR, Yates JRW, Fletcher AE, European Eye (EUREYE) Study Group (2017) Association of C-reactive protein genetic polymorphisms with late age-related macular degeneration. JAMA Ophthalmol 135(9):909
Stephen P. Daiger, Lori S. Sullivan, Sara J. Bowne, Chapter 31—Genetic mechanisms of retinal disease. In: Stephen J. Ryan, SriniVas R. Sadda, David R. Hinton, Andrew P. Schachat, SriniVas R. Sadda, C.P. Wilkinson, Peter Wiedemann (Eds.), Retina, 5th ed., WB Saunders, 2013, pp 624–634, ISBN 9781455707379
Das T, Sen A, Kemph T, Pramanik SR, Mandal C, Mandal C (2003) Induction of glycosylation in human C-reactive protein under different pathological conditions. Biochem J:373
Di JY, Dai ML, Zhang ZX (2018) ENPP1 K121Q (rs1044498  C  >  A) genetic polymorphism confers a high risk of susceptibility to coronary heart disease. Medicine 97(27)
Falconer JS, Fearon KC, Ross JA, Elton R, Wigmore SJ, Garden OJ, Carter DC (1995) Acute-phase protein response and survival duration of patients with pancreatic cancer. Cancer 75(8):2077–2082
Fang D, Yu Y (2017) C-reactive protein Gene rs1205 polymorphism is not associated with the risk of colorectal cancer. Biosci Rep 37(4)
Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2018) Global cancer observatory: cancer today. International Agency for Research on Cancer, Lyon, France. Available from https://gco.iarc.fr/today, accessed January 11, 2020
Frank R, Hargreaves R (2003) Clinical biomarkers in drug discovery and development Nat. Rev Drug Disc 2:566
Heikkilä K, Silander K, Salomaa V, Jousilahti P, Koskinen S, Pukkala E, Perola M (2011) C-reactive protein-associated genetic variants and cancer risk: findings from FINRISK 1992, FINRISK 1997 and Health 2000 studies. Eur J Cancer 47(3):404–412
Hudert CA, Selinski S, Rudolph B, Bläker H, Loddenkemper C, Thielhorn R, Berndt N, Golka K, Cadenas C, Reinders J, Henning S, Bufler P, Jansen PLM, Holzhütter HG, Meierhofer D, Hengstler JG, Wiegand S (2019) Genetic determinants of steatosis and fibrosis progression in paediatric non-alcoholic fatty liver disease. Liver Int 39:540–556
**g L, Xuedan J, Zhongfu Y, Haifeng Q, Ruixia G (2017) C-reactive protein and risk of ovarian cancer: a systematic review and meta-analysis. Medicine 96(34):e7822
Karakiewicz PI, Hutterer GC, Trinh QD, Jeldres C, Perrotte P, Gallina A, Tostain J, Patard JJ (2007) C-reactive protein is an informative predictor of renal cell carcinoma-specific mortality: a European study of 313 patients. Cancer 110(6):1241–1247
Kito M et al (2015) CRP 1846C>T Genetic polymorphism is associated with lymph node metastasis and/or severe lymphatic invasion in endometrial cancer. Tohoku J Exp Med 237(1):25–30
Ko YJ, Kwon YM, Kim KH, Choi HC, Chun SH, Yoon HJ, Goh E, Cho B, Park M (2012) High-sensitivity C-reactive protein levels and cancer mortality. Cancer Epidemiol Biomark Prev 21(11):2076–2086
Kushner I, Rzewnicki D, Samols D (2006) What does minor elevation of C-reactive protein signify? Am J Med 119(2):166.e17–166.e28
Lee S et al (2011) High-sensitivity C-reactive protein and cancer. J Epidemiol 21(3):161–168
Legouffe E, Rodriguez C, Picot MC, Richard B, Klein B, Rossi JF, Commes T (1998 Oct) C-reactive protein serum level is a valuable and simple prognostic marker in non Hodgkin’s lymphoma. Leuk Lymphoma 31(3–4):351–357
Lei KJ, Liu T, Zon G, Soravia E, Liu TY, Goldman ND (1985) Genomic DNA sequence for human C-reactive protein. J Biol Chem 260:13377
Livanainen S, Ahvonen J, Knuuttila A, Tiainen S, Koivunen JP, Elevated CRP (2019) Levels indicate poor progression-free and overall survival on cancer patients treated with PD-1 inhibitors. ESMO Open 4:e000531. https://doi.org/10.1136/esmoopen-2019-000531
Luan Y-Y, Yao Y-M (2018) The clinical significance and potential role of C-reactive protein in chronic inflammatory and neurodegenerative diseases. Front Immunol 9:1302
Lukaszewicz-Zając M, Mroczko B, Gryko M, Kędra B, Szmitkowski M (2011) Comparison between clinical significance of serum proinflammatory proteins (IL-6 and CRP) and classic tumor markers (CEA and CA 19-9) in gastric cancer. Clin Exp Med 11(2):89–96. https://doi.org/10.1007/s10238-010-0114-5. Epub 2010 Oct 12
Martin D, Rödel F, Balermpas P, Winkelmann R, Fokas E, Rödel C (2019) C-reactive protein-to-albumin ratio as prognostic marker for anal squamous cell carcinoma treated with chemoradiotherapy. Front Oncol 9:1200. https://doi.org/10.3389/fonc.2019.01200
McFadyen JD, Kiefer J, Braig D, Loseff-Silver J, Potempa LA, Eisenhardt SU, Peter K (2018) Dissociation of C-reactive protein localizes and amplifies inflammation: evidence for a direct biological role of C-reactive protein and its conformational changes. Front Immunol 9:1351. https://doi.org/10.3389/fimmu.2018.01351
Nakamura T, Matsumine A, Matsubara T, Asanuma K, Uchida A, Sudo A (2012) Clinical significance of pretreatment serum C-reactive protein level in soft tissue sarcoma. Cancer 118(4):1055–1061
Ochrietor JD, Harrison KA, Zahedi K, Mortensen RF (2000) Role of STAT3 and C/EBP in cytokine-dependent expression of the mouse serum amyloid P-component (SAP) and C-reactive protein (CRP) genes. Cytokine 12(7):888–899
Patel DN, King CA, Bailey SR, Holt JW, Venkatachalam K, Agrawal A, Valente AJ, Chandrasekar B (2007) Interleukin-17 stimulates C-reactive protein expression in hepatocytes and smooth muscle cells via p38 MAPK and ERK1/2-dependent NFkappaB and C/EBPbeta activation. J Biol Chem 282:27229–27238
Pepys MB, Hirschfield GM (2003) C-reactive protein: a critical update. J Clin Invest 111(12):1805–1812
Pierce BL, Ballard-Barbash R, Bernstein L, Baumgartner RN, Neuhouser ML, Wener MH, Baumgartner KB, Gilliland FD, Sorensen BE, McTiernan A, Ulrich CM (2009) Elevated biomarkers of inflammation are associated with reduced survival among breast cancer patients. J Clin Oncol 27(21):3437–3444. https://doi.org/10.1200/JCO.2008.18.9068. Epub 2009 May 26
Redmond HP (2003) Systemic inflammatory response predicts survival following curative resection of colorectal cancer. Br J Surg 90(7):889. author reply 889
Salazar J, MartÃnez MS, Chávez-Castillo M, Núñez V, Añez R, Torres Y, Toledo A, ChacÃn M, Silva C, Pacheco E, Rojas J (2014a) C-reactive protein: an in-depth look into structure, function, and regulation. Int Sch Res Notices:653045. 11 pages Review Article
Salazar J, MartÃnez MS, Chávez-Castillo M, Núñez V, Añez R, Torres Y, Toledo A, ChacÃn M, Silva C, Pacheco E, Rojas J, Bermúdez V (2014b) C-reactive protein: an in-depth look into structure, function, and regulation. Int Sch Res 2014:653045. 11 p. https://doi.org/10.1155/2014/653045
Salazar J, MartÃnez MS, Chávez-Castillo M, Núñez V, Añez R, Torres Y, Toledo A, ChacÃn M, Silva C, Pacheco E, Rojas J (2014c) C-reactive protein: an in-depth look into structure, function, and regulation. Int Sch Res
Scott HR, McMillan DC, Forrest LM, Brown DJ, McArdle CS, Milroy R (2002) The systemic inflammatory response, weight loss, performance status and survival in patients with inoperable non-small cell lung cancer. Br J Cancer 87(3):264–267
Selvaraj SM, Christina JJ, Gurumoorthy S, Jayaraman BG, Vellaichamy A (2019) Association of − 757T > C Polymorphism of C-reactive protein gene with chronic periodontitis of South Indian Population. Inflamm Res 68(5):347–349
Shimura T, Kitagawa M, Yamada T, Ebi M, Mizoshita T, Tanida S, Kataoka H, Kamiya T, Joh T (2012) C-reactive protein is a potential prognostic factor for metastatic gastric cancer. Anticancer Res 32(2):491–496
Shrive AK, Cheetham GM, Holden D et al (1996) Three dimensional structure of human C-reactive protein. Nat Struct Biol 3(4):346–354
Sproston NR, Ashworth JJ (2018) Role of C-reactive protein at sites of inflammation and infection. Front Immunol 9:754
Stark JR, Li H, Kraft P et al (2009) Circulating prediagnostic interleukin-6 and C-reactive protein and prostate cancer incidence and mortality. Int J Cancer 124(11):2683–2689. https://doi.org/10.1002/ijc.24241
Su HX, Zhou HH, Wang MY et al (2014a) Mutations of C-reactive protein (CRP) -286 SNP, APC and p53 in colorectal cancer: implication for a CRP-Wnt crosstalk. PLoS One 9(7):e102418. Published 2014 Jul 15. https://doi.org/10.1371/journal.pone.0102418
Su H-X et al (2014b) Mutations of C-reactive protein (CRP) -286 SNP, APC and p53 in colorectal cancer: implication for a CRP-Wnt crosstalk. PLoS One 9(7)
Szalai AJ, Wu J, Lange EM, McCrory MA, Langefeld CD, Williams A, Zakharkin SO, George V, Allison DB, Cooper GS, **e F, Fan Z, Edberg JC, Kimberly RP (2005) Single-nucleotide polymorphisms in the C-reactive protein (CRP) gene promoter that affect transcription factor binding, alter transcriptional activity, and associate with differences in baseline serum CRP level. J Mol Med 83(6):440–447
Thiele JR, Habersberger J, Braig D, Schmidt Y, Goerendt K, Maurer V, Bannasch H, Scheichl A, Woollard KJ, von Dobschütz E, Kolodgie F, Virmani R, Stark GB, Peter K, Eisenhardt SU (2014) Dissociation of pentameric to monomeric C-reactive protein localizes and aggravates inflammation: in vivo proof of a powerful proinflammatory mechanism and a new anti-inflammatory strategy. Circulation 130(1):35–50
Thompson D, Pepys MB, Wood SP (1999) The physiological structure of human C-reactive protein and its complex with phosphocholine. Structure 7:169
Tillett WS, Francis T (1930) Serological reactions in Pneumonia with a non-protein somatic fraction of Pneumococcus. J Exp Med 52(4):561–571
Wang MY, Zhou HH, Zhang SC et al (2014) Recurrent mutations at C-reactive protein gene promoter SNP position −286 in human cancers. Cell Res 24(4):505–508. https://doi.org/10.1038/cr.2014.7
Wang S, Zhong H, Lu M, Song G, Zhang X, Lin M, Yang S, Qian M (2018) Higher serum C reactive protein determined C Reactive protein single-nucleotide polymorphisms are involved in inherited depression. Psychiatry Invest 15(8):824–828
Wang X, Dai JY, Albanes D, Arndt V, Berndt SI, Bézieau S, Brenner H, Buchanan DD, Butterbach K, Caan B, Casey G, Campbell PT, Chan AT, Chen Z, Chang-Claude J, Cotterchio M, Easton DF, Giles GG, Giovannucci E, Grady WM, Hoffmeister M, Hopper JL, Hsu L, Jenkins MA, Joshi AD, Lampe JW, Larsson SC, Lejbkowicz F, Li L, Lindblom A, Marchand LL, Martin V, Milne RJ, Moreno V, Newcomb PA, Offitt K, Ogino S, Pharoah PDP, Pinchev M, Potter JD, Rennert HS, Rennert G, Saliba W, Schafmayer C, Schoen RE, Schrotz-King P, Slattery ML, Song M, Stegmaier C, Weinstein SJ, Wolk A, Woods MO, Wu AH, Gruber SB, Peters U, White E (2019a) Mendelian randomization analysis of C-reactive protein on colorectal cancer risk. Int J Epidemiol 48(3):767–780
Wang X, Liu S, Zhao X, Fang E, Zhao X (2019b) The value of C-reactive protein as an independent prognostic indicator for disease-specific survival in patients with soft tissue sarcoma: a meta-analysis. PLoS One 14(7):e0219215
Woo P, Korenberg JR, Whitehead AS (1985) Characterization of genomic and complementary DNA sequence of human C-reactive protein, and comparison with the complementary DNA sequence of serum amyloid P component. J Biol Chem 260:13384
Wu Q, Nie J, Wu F, Zou X, Chen F (2018) Association of single-nucleotide polymorphisms of C-reactive protein gene with susceptibility to infantile sepsis in Southern China. Med Sci Monit 24:590–595
Yibulaiyin H, Sun H, Yang Y (2017) Depression is associated with CRP SNPs in patients with family history. Transl Neurosci 8:201–206. https://doi.org/10.1515/tnsci-2017-0027. Published 2017 Dec 29
Young DP, Kushner I, Samols D (2008) Binding of C/EBPβ to the C-Reactive Protein (CRP) Promoter in Hep3B cells is associated with transcription of CRP mRNA. J Immunol 181(4):2420–2427
Zhang D, Sun M, Samols D (1996a) Kushner (I) STAT3 participates in transcriptional activation of the C-reactive protein gene by Interleukin-6 (*). J Biol Chem 271:9503–9509
Zhang D, Sun M, Samols D, Kushner I (1996b) STAT3 participates in transcriptional activation of the C-reactive protein gene by interleukin-6. J Biol Chem 271:9503–9509
Zhang SM, Buring JE, Lee IM, Cook NR, Ridker PM (2005) C-reactive protein levels are not associated with increased risk for colorectal cancer in women. Obstet Gynecol 105(6):1480
Zhang S, Thakur A, Liang Y, Wang T, Gao L, Yang T, Li Y, Geng T, ** T, Chen T, Liu JJ, Chen M (2015) Polymorphisms. In C-reactive ProteinandGlypican-5 are associated with lung cancer risk andgartrokine-1influences cisplatin-based chemotherapy response in a Chinese Han population. Dis Markers 2015:1–8
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Dasgupta, R., Ghosh, S. (2020). Role of SNP in CRP and Biology of Cancer. In: Ansar, W., Ghosh, S. (eds) Clinical Significance of C-reactive Protein. Springer, Singapore. https://doi.org/10.1007/978-981-15-6787-2_6
Download citation
DOI: https://doi.org/10.1007/978-981-15-6787-2_6
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-15-6786-5
Online ISBN: 978-981-15-6787-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)